Adiponectin and colorectal cancer.

Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation. Anticancer Res (2016) 0.75

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med (2001) 16.51

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun (1999) 14.25

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature (2003) 9.79

A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem (1995) 9.72

Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem (2002) 4.60

Overweight, obesity, and cancer risk. Lancet Oncol (2002) 4.44

Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 4.17

T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A (2004) 3.90

Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition (1999) 3.84

Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr (2007) 3.66

Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst (2005) 3.22

Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev (2007) 3.16

Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes (2006) 3.14

Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88

Adiponectin and breast cancer risk. J Clin Endocrinol Metab (2004) 2.72

Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol (2012) 2.48

Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev (2004) 2.40

Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res (2003) 2.35

Adiponectin and cancer: a systematic review. Br J Cancer (2006) 2.33

Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control (1994) 2.33

Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem (2003) 2.29

A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2005) 2.15

Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett (2005) 2.13

AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol (2010) 2.11

Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab (2007) 2.07

Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut (2008) 2.05

Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res (2006) 2.03

RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Res (2005) 2.01

Influence of obesity on the risk of developing colon cancer. Gut (2005) 1.93

Epidemiology of colorectal cancer. Br Med Bull (2002) 1.87

Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab (2004) 1.86

BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord (2004) 1.85

Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis (2009) 1.84

Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study. Am J Gastroenterol (2009) 1.79

Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia. Dig Dis Sci (2008) 1.76

Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res (2006) 1.75

Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol (2007) 1.73

Association of obesity and cancer risk in Canada. Am J Epidemiol (2004) 1.71

Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab (2006) 1.71

Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun (2006) 1.69

Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev (2002) 1.68

Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice. Gut (2012) 1.65

Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci (2010) 1.62

Plasma adiponectin and gastric cancer. Clin Cancer Res (2005) 1.62

Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res (2005) 1.61

Prostate cancer and adiponectin. Urology (2005) 1.59

Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomarkers Prev (2004) 1.59

Association between adiponectin, insulin resistance, and endometrial cancer. Cancer (2006) 1.55

T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res (2008) 1.54

Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab (2003) 1.52

Elevated circulating adiponectin and elevated insulin sensitivity in adiponectin transgenic mice are not associated with reduced susceptibility to colon carcinogenesis. Int J Cancer (2009) 1.50

Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab (2006) 1.47

Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol (2010) 1.44

Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun (2005) 1.42

The signal pathways in azoxymethane-induced colon cancer and preventive implications. Cancer Biol Ther (2009) 1.34

LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells. Oncogene (2009) 1.34

Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond) (2007) 1.32

Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology (2006) 1.32

Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomarkers Prev (2007) 1.31

Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology (2012) 1.30

Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem Biophys Res Commun (2005) 1.28

Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res (2010) 1.26

Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology (2010) 1.23

Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol (2009) 1.22

Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis (2008) 1.21

Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer (2007) 1.20

Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.19

Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer (2008) 1.18

Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J Gastroenterol (2010) 1.17

The effect of body weight reduction on the incidence of colorectal adenoma. Am J Gastroenterol (2008) 1.13

Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett (2006) 1.10

Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept (2006) 1.10

Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci (2007) 1.08

Adiponectin and adiponectin receptor in relation to colorectal cancer progression. Int J Cancer (2010) 1.08

Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma. J Dig Dis (2011) 1.08

Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology (2006) 1.07

Adiponectin--it's all about the modifications. Int J Biochem Cell Biol (2010) 1.06

Adipokine regulation of colon cancer: adiponectin attenuates interleukin-6-induced colon carcinoma cell proliferation via STAT-3. Mol Carcinog (2010) 1.04

Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK. Hum Mol Genet (2009) 1.03

Visceral fat volume and the prevalence of colorectal adenoma. Am J Epidemiol (2009) 1.03

Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy. J Urol (2005) 1.03

Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population. BMC Med Genet (2011) 1.02

Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study. Carcinogenesis (2012) 1.02

Abdominal visceral adipose tissue predicts risk of colorectal adenoma in both sexes. Clin Gastroenterol Hepatol (2010) 1.00

Adiponectin in relation to childhood myeloblastic leukaemia. Br J Cancer (2006) 1.00

Loss of adiponectin promotes intestinal carcinogenesis in Min and wild-type mice. Gastroenterology (2011) 0.98

Prognostic significance of adiponectin levels in non-metastatic colorectal cancer. Anticancer Res (2007) 0.97

Control of cell growth and survival by enzymes of the fatty acid synthesis pathway in HCT-116 colon cancer cells. Clin Cancer Res (2008) 0.96

Prognostic significance of serum adipokine levels in colorectal cancer patients. Anticancer Res (2009) 0.96

Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metabolism (2011) 0.95

Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis. World J Gastroenterol (2014) 0.94

The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem Biophys Res Commun (2006) 0.93

Insulin, leptin, and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine. Am J Physiol Gastrointest Liver Physiol (2007) 0.93

Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue. Oncol Rep (2008) 0.92

Adiponectin deficiency: role in chronic inflammation induced colon cancer. Biochim Biophys Acta (2011) 0.92

Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci (2008) 0.91

Adiponectin supports cell survival in glucose deprivation through enhancement of autophagic response in colorectal cancer cells. Cancer Sci (2011) 0.89